miR-1915-3p inhibits Bcl-2 expression in the development of gastric cancer.
Many gene expressions changed during the development of gastric cancer, and non-coding RNAs including microRNAs (miRNAs) have been found to regulate cancer progression by participating in the process of tumor cell growth, migration, invasion and apoptosis. Our previous study has identified 29 miRNAs that are highly expressed in gastric cancer stem cells. One of these miRNAs, miR-1915-3p, has shown great potential as a diagnostic and prognostic biomarker for the cancers in liver, colon and thyroid, as well as in immune and kidney diseases. Herein, we found that miR-1915-3p exhibited low expression level in differentiated gastric cancer cell lines and gastric cancer tissues. It was found that the miR-1915-3p inhibited the growth of gastric cancer cells and thus promoted cell apoptosis. We discovered that the expressions of miR-1915-3p were significantly correlated to the lymph node metastasis and overall survival of patients with gastric cancer. Further study showed that there was a negative correlation between miR-1915-3p and Bcl-2 (B cell lymphoma/leukemia-2) expression, suggesting that Bcl-2 was a target gene of miR-1915-3p. Hence, miR-1915-3p possibly contributes to the development and progression of gastric cancer by inhibiting the anti-apoptotic protein Bcl-2. The finding provides a potential therapeutic strategy for gastric cancer.
['Cui|Hong-Wei|HW|', 'Han|Wen-Yan|WY|', 'Hou|Li-Na|LN|', 'Yang|Ling|L|', 'Li|Xian|X|', 'Su|Xiu-Lan|XL|0000-0001-6527-7412']
D000328:Adult D045744:Cell Line, Tumor D005260:Female D015972:Gene Expression Regulation, Neoplastic D006801:Humans D008297:Male D035683:MicroRNAs D008875:Middle Aged D019253:Proto-Oncogene Proteins c-bcl-2 D012334:RNA, Neoplasm D013274:Stomach Neoplasms
miR-1915-3p Bcl-2 Gastric cancer Apoptosis Bcl-XL